161 related articles for article (PubMed ID: 26794662)
1. Development of a human physiologically based pharmacokinetic (PBPK) model for dermal permeability for lindane.
Sawyer ME; Evans MV; Wilson CA; Beesley LJ; Leon LS; Eklund CR; Croom EL; Pegram RA
Toxicol Lett; 2016 Mar; 245():106-9. PubMed ID: 26794662
[TBL] [Abstract][Full Text] [Related]
2. Parameters for pyrethroid insecticide QSAR and PBPK/PD models for human risk assessment.
Knaak JB; Dary CC; Zhang X; Gerlach RW; Tornero-Velez R; Chang DT; Goldsmith R; Blancato JN
Rev Environ Contam Toxicol; 2012; 219():1-114. PubMed ID: 22610175
[TBL] [Abstract][Full Text] [Related]
3. Comparative percutaneous absorption of lindane and permethrin.
Franz TJ; Lehman PA; Franz SF; Guin JD
Arch Dermatol; 1996 Aug; 132(8):901-5. PubMed ID: 8712839
[TBL] [Abstract][Full Text] [Related]
4. Effect of soil loading on dermal absorption efficiency from contaminated soils.
Duff RM; Kissel JC
J Toxicol Environ Health; 1996 May; 48(1):93-106. PubMed ID: 8637061
[TBL] [Abstract][Full Text] [Related]
5. A physiologically based pharmacokinetic model of organophosphate dermal absorption.
van der Merwe D; Brooks JD; Gehring R; Baynes RE; Monteiro-Riviere NA; Riviere JE
Toxicol Sci; 2006 Jan; 89(1):188-204. PubMed ID: 16221965
[TBL] [Abstract][Full Text] [Related]
6. A distributed parameter physiologically-based pharmacokinetic model for dermal and inhalation exposure to volatile organic compounds.
Roy A; Weisel CP; Lioy PJ; Georgopoulos PG
Risk Anal; 1996 Apr; 16(2):147-60. PubMed ID: 8638037
[TBL] [Abstract][Full Text] [Related]
7. Effect of PBPK model structure on interpretation of in vivo human aqueous dermal exposure trials.
Norman AM; Kissel JC; Shirai JH; Smith JA; Stumbaugh KL; Bunge AL
Toxicol Sci; 2008 Jul; 104(1):210-7. PubMed ID: 18381354
[TBL] [Abstract][Full Text] [Related]
8. Malathion dermal permeability in relation to dermal load: Assessment by physiologically based pharmacokinetic modeling of in vivo human data.
Bogen KT; Singhal A
J Environ Sci Health B; 2017 Feb; 52(2):138-146. PubMed ID: 27820679
[TBL] [Abstract][Full Text] [Related]
9. Multilayered dermal subcompartments for modeling chemical absorption.
Bookout RL; McDaniel CR; Quinn DW; McDougal JN
SAR QSAR Environ Res; 1996; 5(3):133-50. PubMed ID: 9114511
[TBL] [Abstract][Full Text] [Related]
10. The percutaneous absorption and skin distribution of lindane in man. I. In vivo studies.
Dick IP; Blain PG; Williams FM
Hum Exp Toxicol; 1997 Nov; 16(11):645-51. PubMed ID: 9426365
[TBL] [Abstract][Full Text] [Related]
11. Assessment of dermal absorption by thermogravimetric analysis: Development of a diffusion model based on Fick's second law.
Rauma M; Johanson G
J Pharm Sci; 2009 Nov; 98(11):4365-75. PubMed ID: 19283759
[TBL] [Abstract][Full Text] [Related]
12. Dermic diffusion and stratum corneum: a state of the art review of mathematical models.
Couto A; Fernandes R; Cordeiro MN; Reis SS; Ribeiro RT; Pessoa AM
J Control Release; 2014 Mar; 177():74-83. PubMed ID: 24362041
[TBL] [Abstract][Full Text] [Related]
13. In Silico Estimation of Skin Concentration Following the Dermal Exposure to Chemicals.
Hatanaka T; Yoshida S; Kadhum WR; Todo H; Sugibayashi K
Pharm Res; 2015 Dec; 32(12):3965-74. PubMed ID: 26195007
[TBL] [Abstract][Full Text] [Related]
14. PBPK models for the prediction of in vivo performance of oral dosage forms.
Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
[TBL] [Abstract][Full Text] [Related]
15. Significance of the dermal route of exposure to risk assessment.
Mattie DR; Grabau JH; McDougal JN
Risk Anal; 1994 Jun; 14(3):277-84. PubMed ID: 8029499
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the human skin grafted onto nude mouse model with in vivo and in vitro models in the prediction of percutaneous penetration of three lipophilic pesticides.
Capt A; Luzy AP; Esdaile D; Blanck O
Regul Toxicol Pharmacol; 2007 Apr; 47(3):274-87. PubMed ID: 17239512
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Age-Related Pyrethroid Pharmacokinetic Differences in Rats: Physiologically-Based Pharmacokinetic Model Development Using In Vitro Data and In Vitro to In Vivo Extrapolation.
Song G; Moreau M; Efremenko A; Lake BG; Wu H; Bruckner JV; White CA; Osimitz TG; Creek MR; Hinderliter PM; Clewell HJ; Yoon M
Toxicol Sci; 2019 Jun; 169(2):365-379. PubMed ID: 30768128
[TBL] [Abstract][Full Text] [Related]
18. Toward a better understanding of pesticide dermal absorption: diffusion model analysis of parathion absorption in vitro and in vivo.
Miller MA; Kasting GB
J Toxicol Environ Health A; 2010; 73(4):284-300. PubMed ID: 20077298
[TBL] [Abstract][Full Text] [Related]
19. The percutaneous absorption and skin distribution of lindane in man. II. In vitro studies.
Dick IP; Blain PG; Williams FM
Hum Exp Toxicol; 1997 Nov; 16(11):652-7. PubMed ID: 9426366
[TBL] [Abstract][Full Text] [Related]
20. A generic, cross-chemical predictive PBTK model with multiple entry routes running as application in MS Excel; design of the model and comparison of predictions with experimental results.
Jongeneelen FJ; Berge WF
Ann Occup Hyg; 2011 Oct; 55(8):841-64. PubMed ID: 21998005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
